Etanercept Therapy for Sjogren's Syndrome - Related Studies

Etanercept Therapy for Sjogren's Syndrome

This study has been completed.

Study NCT00001954. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Sjogren's Syndrome

2	Additional conditions recognized in this trial
		Syndrome

3	More general conditions related to this trial
		Arthritis
		Arthritis, Rheumatoid
		Autoimmune Diseases
		Connective Tissue Diseases
		Disease
		Dry Eye Syndromes
		Eye Diseases
		Immune System Diseases
		Joint Diseases
		Lacrimal Apparatus Diseases
		Mouth Diseases
		Musculoskeletal Diseases
		Pathologic Processes
		Rheumatic Diseases
		Salivary Gland Diseases
		Stomatognathic Diseases
		Xerostomia

4	Interventions listed in this trial
		Etanercept

5	Additional drug interventions recognized in this trial
		TNFR-Fc fusion protein

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Immunologic Factors
		Immunosuppressive Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Dental and Craniofacial Research (NIDCR)